Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06635629 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
NotableTrial status: Not Yet Recruiting to RecruitingSite details revisedv24Show 1 more changeShow less
Site details revised
MinorStart date: Dec 8, 2024 to Dec 9, 2024v23
MinorStart date: Dec 5, 2024 to Dec 8, 2024v22
MinorStart date: Dec 2, 2024 to Dec 5, 2024v21
MinorStart date: Dec 1, 2024 to Dec 2, 2024v20
MinorStart date: Nov 28, 2024 to Dec 1, 2024v19
MinorStart date: Nov 26, 2024 to Nov 28, 2024v18
MinorStart date: Nov 25, 2024 to Nov 26, 2024v17
MinorStart date: Nov 24, 2024 to Nov 25, 2024v16
MinorStart date: Nov 21, 2024 to Nov 24, 2024v15
MinorStart date: Nov 20, 2024 to Nov 21, 2024v14
MinorStart date: Nov 19, 2024 to Nov 20, 2024v13
MinorStart date: Nov 18, 2024 to Nov 19, 2024v12
MinorStart date: Nov 17, 2024 to Nov 18, 2024v11
MinorStart date: Nov 14, 2024 to Nov 17, 2024v10
MinorStart date: Nov 13, 2024 to Nov 14, 2024v9
MinorStart date: Nov 12, 2024 to Nov 13, 2024v8
MinorStart date: Nov 11, 2024 to Nov 12, 2024v7
MinorStart date: Nov 10, 2024 to Nov 11, 2024v6
MinorStart date: Nov 7, 2024 to Nov 10, 2024v5
MinorStart date: Nov 5, 2024 to Nov 7, 2024v4
Minor2 versionsRe-verified since Oct 10, 2024, no change to tracked fieldsv2-v3
MinorStudy First Submitted
Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Background:
Cushing syndrome (CS) is a set of diseases that develop when the body produces too much adrenocorticotropic hormone (ACTH). ACTH stimulates the production of a hormone called cortisol. Excess cortisol can cause serious issues, such as diabetes, high blood pressure, weight gain, and mood changes. Diagnosing CS early can be difficult. One test used to diagnose CS, the desmopressin (Desmo) stimulation test (DesmoST), has not been studied in enough people to know how accurate it is.
Objective:
To find ways to improve the DesmoST. Researchers especially want to learn more about how well the DesmoST identifies people with specific ACTH CSs: Cushing disease (CD) and ectopic ACTH syndrome (EAS).
Eligibility:
People aged 18 to 70 years who have or may have CS, especially CD or EAS. Healthy volunteers are also needed.
Design:
Participants with CS will have 3 DesmoSTs at least 48 hours apart. The procedure for each is as follows:
They will limit their fluid intake the day before each test. They will have nothing to eat or drink for 12 hours before the test.
For 1 of the tests, they will take a pill that contains a hormone (dexamethasone). They will take it around 11 pm the day before the test.
Desmo is given through a tube attached to a needle inserted into a vein.
Blood will be drawn a total of 6 times before and after the desmo is given.
Healthy volunteers will have 4 DesmoSTs. These will be 2 to 14 days apart.
All participants will have follow-up visits 3 to 5 days after each test. These visits may be by phone.